|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Amortization of operating lease right-of-use asset | ||||
| Investment loss | ||||
| Changes in fair value of warrant liabilities | ||||
| Change in fair value of convertible notes | ||||
| Issuance costs and discount on convertible notes | ||||
| Loss of impairment on investments | ||||
| Impairment of property and equipment | ||||
| Disposal loss of property and equipment | ||||
| Provision for doubtful accounts | ||||
| Lawsuit provision | ||||
| Inventory write-down | ||||
| Inventory write-off | ||||
| Allowance for expected credit losses | ||||
| Impairment loss of advance to suppliers and prepaid expenses and other current assets | ||||
| Financial expenses on PIPE | ||||
| Gain from dissolution of a subsidiary | ||||
| Interests on loans from a third party | ||||
| Interests on loans from a related party | ||||
| Expense paid by the related parties on behalf of the Group | ||||
| Expenses paid by related parties on behalf of the Company | ||||
| Share-based compensation | ||||
| Accounts payable exemption treated as capital injection | ||||
| Loss on early termination of operating lease | ||||
| Changes in assets and liabilities: | ||||
| Accounts receivable, current | ||||
| Advance to supplier | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| Accounts receivable, non-current | ||||
| Amounts due from/due to related parties | ||||
| PIPE escrow account | ||||
| Operating lease | ||||
| Accounts payable | ||||
| Advance from customers | ||||
| Accrued expenses and other current liabilities | ||||
| Net cash (used in) provided by operating activities | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
| Purchases of property and equipment | ||||
| Purchases of intangible asset | ||||
| Proceeds from disposal of property and equipment | ||||
| Loan to a related party | ||||
| Net cash provided by (used in) investing activities | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
| Loan proceeds from related parties | ||||
| Repayments of loan from a related party | ||||
| Repayments of loan from third parties | ||||
| Proceeds from convertible notes | ||||
| Proceeds from shareholder contributions | ||||
| Payments of financial expenses | ||||
| Proceeds from execution of warrants | ||||
| Net cash provided by (used in) financing activities | ||||
| Effect of exchange rate changes | ||||
| Net increase/(decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents and restricted cash, at beginning of the period | ||||
| Cash and cash equivalents and restricted cash, at end of the period | ||||
| SUPPLEMENTAL DISCLOSURE OF NON CASH FLOW INFORMATION: | ||||
| Expenses paid by related parties on behalf of the Company | ||||
| Issuance of shares to acquire16.58% equity interest in Aitos (Note 7 and Note 22) | ||||
| Issuance of shares for debt extinguishment | ||||
| Issuance of shares to settle employee compensation liabilities | ||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||
| Interest paid | ||||
Loading...